New Marketplace

The Unrealized Potential of EMRs: Interoperability and the Opportunity for Disruption

Roundtable · April 25, 2018

Part 2 of a two-part series.
 

Steven Seltzer Andrew Menard Clayton Christensen Edward Prewitt Electronic Medical Records Roundtable Head Shots

The Participants:

  • Steven Seltzer, MD, Radiology Department Chair Emeritus at Brigham and Women’s Hospital and Distinguished Professor at Harvard Medical School
  • Andrew Menard, JD, Executive Director of Radiology at Brigham and Women’s Hospital
  • Clayton M. Christensen, PhD, Kim B. Clark Professor of Business Administration at Harvard Business School
  • Edward Prewitt, Editorial Director for NEJM Catalyst, moderator

 

Ed Prewitt:  The lack of interoperability is a criticism that has been made of the meaningful use funds investment. It’s like the one thing that wasn’t required for EMRs, and yet what I’m taking from this conversation is perhaps that would not have made a difference. Clay, what you’re saying is there’s a requirement of technological maturity, and there’s essentially growth pains that every industry has to go through.

Growth Pains

 

Clayton Christensen:  That’s right. Here’s a way to think about it. There are two types of architectures in the world. One type of architecture we would call an interdependent architecture, and that’s defined by, everything you do to one piece has implications for how you do the other pieces of the system. If you do one thing here, you have to do something else there, and that means that you have to be integrated. You have to do everything in order to do anything in that world, which we define as interdependent architecture. And almost always at the beginning of an industry’s history, the architecture has to be interdependent because you can’t articulate how this fits with that. That has to emerge. Nobody is smart enough to know at the beginning exactly how they [should fit].

Steven Seltzer:  And that’s where we are now, effectively.

Christensen:  That’s right, and people who play that game well are big companies that put their arms around the whole thing, and when they change this, they can say, “All right, change that.” But at the other end of the spectrum — and this is a spectrum — at the other end are architectures that are modular. And when it’s modular, I know exactly if I change this in this component, I have to change that in that component, and when you understand what each piece has to contribute to the whole, then you don’t have to do the whole thing anymore. . . .  But [modularity] comes toward the end because you need to be able to articulate what you need, how to measure what you need, and so on.

New Approaches

 

Prewitt:  What is it going to take to move to EMRs that work the way that the buyers would like them to and that everyone intended, and how long is it going to take? Steven?

Seltzer:  You know, Ed, we also have billions of dollars in sunk costs, so that for a large health system in an aggressive way to say, “I don’t want this anymore,” that’s going to be a very difficult decision to do. All these things collude, I think, to say it’s going to take a while to work our way out. . . . The current state is pretty fixed for quite some time, and there will be incremental progress, of course. Every year, there’s a new software release, and it’s better, but nothing dramatic until something else changes.

Prewitt:  What are the factors, the most important factors, that need to be solved in order to move to a solution?

Andrew Menard:  Well, you even have to define solution, I suppose, but if we’re thinking about the word interoperability, if we define solution from the perspective of the patient and the ability to move easily, to have continuity of care and bring their information with them, just that basic idea, I think that — again, curious about my co-panelists’ view — there are some opportunities for outsiders in that case. And there are some ways to use things that go beyond the control of the health systems where patients are more active; patients [become] more IT literate, and there are other tools.

There are companies as big as Apple and many small ones who may be able to offer utilities that assist with some of these problems that look like they’re on the fringe right now, but could lead toward solutions that sort of are almost rebellious — that disrupt from the outside. I don’t see a lot of incentive for a big system, as Steven points out, that has put a billion dollars into architecture, into infrastructure, to self-disrupt, and so I think of it as an outsider insurgency.

Seltzer:  That’s what Clay says in his book, that . . . the disruptors will come in with 70% of the capabilities in the existing systems at 1/100 of the cost.

Menard:  And even more orthogonal than that, they’re coming at it from a completely different direction.

Seltzer:  Correct. They say this interdependent architecture just doesn’t fit in health care, so let’s just go about it in a completely different way.

Christensen:  Yeah, almost always, disruption wins by coming at the bottom of the market with simple problems and simple answers to simple problems.

Prewitt:  There are all these other competitors out there outside of the big five or so. Do any of you see positive signs today for, say, a web-based EMR or an EMR that does something different that could work to achieve the ends we’re talking about, or is it going to have to be an orthogonal entrant that nobody’s really thinking about today?

Seltzer:  Well, there’s talk in every company about moving the data off your mainframe, which is basically what we have now, and putting that in the cloud and having all the interactions be through web-based interfaces to get more flexibility. It’s been 5 years or so, and despite the rhetoric about it, there’s not much that has changed in a large interdependent system. Again, if we wait a little bit longer, that may be possible because . . . technology has advanced in things like cloud storage and the desire to amalgamate patient data from across health systems, in the interest of providing better predictive and preventive care and more precision diagnosis. Those things may put pressure because it’s technologically feasible, and there are medical imperatives to do it. Those might accelerate the development of these smaller APIs and web apps.

Moving Forward

 

Prewitt:  NEJM Catalyst’s core audience is health care providers. Our readers are physicians and other clinicians, they’re clinical leaders, they’re health care executives. What should they be doing about the problems that they are experiencing with EMRs? And there are all the problems that we’ve talked about: frustration, cost, burnout, lack of interoperability. Steven?

Seltzer:  I think they will have to be patient because the changes won’t come quickly. They need to be proactive about being honest about what the issues are and not just burying them that “this is just a corporate thing and that we’ll never make it any better.” To paraphrase what Clay was saying, be open to considering different practice and payment systems that could obviate some of the complexity of what EHRs do now, which is billing, because if you’re not on a transactional basis any longer — you do need data, clinical data that should be interoperable — but you don’t need to have the ICD-10 and CPT code for everything that you do because you’re being paid a fixed amount. It’s appealing in that it takes a tremendous amount of overhead and complexity out of the system, and ironically, obviates the need for the important kludgy part of the EMR. Those would be things that they could open to.

Prewitt:  Andrew?

Menard:  Let’s not forget — and I’m not a doctor, but I’m a patient sometimes, and so is everybody I know — [that there are] business decisions where it’s not about optimizing a software system. It’s not about optimizing a financial system, a billing system, a collection system, getting our denials down. We really focus on such things as that. Sometimes denials are OK. And it’s usually a doctor — and I’m going to credit Mass General — they’re very good at standing up and saying, “You’re too focused on denials. You’re too focused on these financial metrics.” Sometimes it’s OK to deliver this care even if we’re not going to get paid. That’s a value system that comes through, a value statement that come through. I think we have to not get too overly into our own science of business.

 

Read Part 1: Why They Fall Short and the Unexpected Source of a Solution.

New call for submissions ­to NEJM Catalyst

Now inviting longform articles

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

More From New Marketplace
Health Care Costs - Cost Transparency Is the Main Change Needed to Support Patients in Lowering the Cost of Care

Survey Snapshot: Is Transparency the Answer?

NEJM Catalyst Insights Council members say that while transparency might be necessary, we have to change the way care is delivered.

Many Stakeholders Share Responsibility for Lowering the Cost of Care

New Marketplace Survey: Patients Lack Information to Reduce the Cost of Care

Efforts to mitigate rising health care costs have left most industry participants — patients, providers, and payers alike — frustrated at the lack of progress. While there is plenty of blame to go around, a significant open question remains: how responsible are patients for reducing costs?

Hip or Knee OA Care Management - Musculoskeletal Institute and Bundled Payment Program at Dell Medical

Bundled Payments Are Moving Upstream

Dell Medical School at The University of Texas at Austin has improved outcomes and reduced costs for musculoskeletal care with a multidisciplinary Musculoskeletal Institute and bundled payment model.

Elements of a Sustainable Complex Care Management Contract

Sustainable Financing for Complex Care Management Is Critical to a Value-Driven Health Care System

Care management should be payer-agnostic at its core.

Comparison of Certain Model Features in Blue Cross NC Blue Premier vs Next-Generation ACO Model vs BCBSMA Alternative Quality Contract

Engineering a Rapid Shift to Value-Based Payment in North Carolina: Goals and Challenges for a Commercial ACO Program

We believe North Carolina can be a model for the nation.

Small Molecule Drugs Facing Generic Competition - Orphan and Non-Orphan Drugs - Orphan Drug Act

It’s Time to Reform the Orphan Drug Act

Three proposals for improving the law to reflect 21st-century drug development practices.

Three-Part Pricing of PCSK9 Inhibitors

A New Model for Pricing Drugs of Uncertain Efficacy

Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients and payers while still paying back investments on the most effective drugs.

what does quality measurement in health care mean

Buzz Survey Report: Addressing the Problems of Quality Measurement

An independent NEJM Catalyst report sponsored by University of Utah Health on patient involvement in quality measurement.

Average HOOS and Average KOOS for patients undergoing hip and knee replacement at CJRI

Building a “Hospital-within-Hospital” Model for Joint Replacements

The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on a common vision to yield drastic improvements in quality, safety, and costs.

Discharge Rates and Follow-Up Internval Dashboard for One Provider at MGH Dermatology

A Successful Pilot to Improve Access by Adjusting Discharge and Follow-Up Rates

Actionable data and modest financial incentives can help motivate clinicians to adjust their behavior around scheduling follow-up appointments.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

Transforming Specialty Practice in Pursuit of…

Despite significant primary care reform around patient-centered medical home models, specialty care remains fragmented, with…

Bundled Payments

61 Articles

Bundled Payments Are Moving Upstream

Dell Medical School at The University of Texas at Austin has improved outcomes and reduced…

New Marketplace Survey: Patients Lack Information…

Efforts to mitigate rising health care costs have left most industry participants — patients, providers,…

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now